Correlation Between Runjian Communication and Nanhua Bio

Can any of the company-specific risk be diversified away by investing in both Runjian Communication and Nanhua Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Runjian Communication and Nanhua Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Runjian Communication Co and Nanhua Bio Medicine, you can compare the effects of market volatilities on Runjian Communication and Nanhua Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Runjian Communication with a short position of Nanhua Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Runjian Communication and Nanhua Bio.

Diversification Opportunities for Runjian Communication and Nanhua Bio

0.74

Correlation Coefficient

Runjian Communication  Nanhua Bio

Poor diversification

The 3 months correlation between Runjian and Nanhua is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Runjian Communication Co and Nanhua Bio Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanhua Bio Medicine and Runjian Communication is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Runjian Communication Co are associated (or correlated) with Nanhua Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanhua Bio Medicine has no effect on the direction of Runjian Communication i.e., Runjian Communication and Nanhua Bio go up and down completely randomly.

Pair Corralation between Runjian Communication and Nanhua Bio

Assuming the 90 days trading horizon Runjian Communication is expected to generate 1.29 times less return on investment than Nanhua Bio. But when comparing it to its historical volatility, Runjian Communication Co is 1.14 times less risky than Nanhua Bio. It trades about 0.17 of its potential returns per unit of risk. Nanhua Bio Medicine is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  697.00  in Nanhua Bio Medicine on September 18, 2024 and sell it today you would earn a total of  312.00  from holding Nanhua Bio Medicine or generate 44.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Runjian Communication Co  vs.  Nanhua Bio Medicine

Runjian Communication

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Runjian Communication Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Runjian Communication sustained solid returns over the last few months and may actually be approaching a breakup point.

Nanhua Bio Medicine

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Nanhua Bio Medicine are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanhua Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Runjian Communication and Nanhua Bio

The main advantage of trading using opposite Runjian Communication and Nanhua Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Runjian Communication position performs unexpectedly, Nanhua Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will offset losses from the drop in Nanhua Bio's long position.

The idea behind Runjian Communication Co and Nanhua Bio Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.